Skip to main content
Clinical Trials/CTRI/2014/11/005227
CTRI/2014/11/005227
Not yet recruiting
未知

Prospective observational study of thromboembolic events in patients of advanced stage Non small cell lung cancer(NSCLC) treated with platinum based chemotherapy.

Tata Memorial Hospital0 sites167 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Tata Memorial Hospital
Enrollment
167
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • INCLUSION CRITERIA:
  • Lung cancer patients (age \>18 years) who are started on platinum based chemotherapy.

Exclusion Criteria

  • EXCLUSION CRITERIA:
  • 1\. Age \<18 years
  • 2\. Patients in whom therapy is discontinued prior to completion of 6 weeks due to any reason.
  • 3\. Presence of any thromboembolic event before start of chemotherapy including deep venous thrombosis (DVT), pulmonary embolus, cerebrovascular accident, and unstable angina/myocardial infarction (MI).
  • 4\.Patients with bleeding diathesis, inherited coagulopathy, and those requiring therapeutic anticoagulation, regular nonsteroidal anti\-inflammatory drugs, and aspirin.
  • 5\. Patients receiving angiogenesis inhibitor drug\- bevacizumab.

Outcomes

Primary Outcomes

Not specified

Similar Trials